Serotype childhood invasive pneumococcal disease has unique characteristics compared to disease caused by other streptococcus pneumoniae serotypes

Pediatric Infectious Disease Journal

Volumn 32, Issue 6, 2013, Pages 614-618

  Fuchs, Inbal ^a   Dagan, Ron ^a   Givon Lavi, Noga ^a   Greenberg, David ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Children; Clinical manifestations; Epidemiology; Invasive pneumococcal disease; Serotype 1

Indexed keywords

ADOLESCENT; ARAB; ARTICLE; BACTEREMIA; BACTERIAL PERITONITIS; BLOOD CULTURE; BRONCHIECTASIS; CHILD; CONGENITAL HEART DISEASE; DOWN SYNDROME; EMPYEMA; HEALTH SERVICE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MORTALITY; MOSLEM; NONHUMAN; PERITONITIS; PLEURA EFFUSION; PNEUMATOCELE; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEPTIC SHOCK; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; THORAX DRAINAGE; AGE; CLASSIFICATION; ETHNIC GROUP; FEMALE; HOSPITALIZATION; INFANT; MALE; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SEROTYPING; STATISTICS; SURVIVAL; COMPLICATION; PNEUMONIA, PNEUMOCOCCAL; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; AGE FACTORS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; ETHNIC GROUPS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; MALE; PERITONITIS; PNEUMONIA, PNEUMOCOCCAL; RETROSPECTIVE STUDIES; RISK FACTORS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; SURVIVAL ANALYSIS;

EID: 84879212678     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31828691cb     Document Type: Article

References (41)

1. Johnson HL, Deloria-Knoll M, Levine OS, et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010;7: e1000348. doi: 10.1371/journal.pmed.1000348.
2. Hausdorff W P, Bryant J, Paradiso PR, et al. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000;30:100-121.
3. Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010;14:e197-e209.
4. Aguiar SI, Brito MJ, Gonçalo-Marques J, et al. Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use. Vaccine. 2010;28:5167-5173.
5. Greenberg D, Givon-Lavi N, Newman N, et al. Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric pneumonia as a means to estimate serotype disease potential. Pediatr Infect Dis J. 2011;30:227-233.
6. Brueggemann AB, Griffiths DT, Meats E, et al. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype-and clone-specific differences in invasive disease potential. J Infect Dis. 2003;187:1424-1432.
7. Brueggemann AB, Peto TE, Crook DW, et al. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis. 2004;190:1203-1211.
8. Shouval DS, Greenberg D, Givon-Lavi N, et al. Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J. 2006;25:602-607.
9. Zemlickova H, Jakubu V, Urbaskova P, et al. Serotype-specific invasive disease potential of Streptococcus pneumoniae in Czech children. J Med Microbiol. 2010;59(Pt 9):1079-1083.
10. Sá-Leão R, Pinto F, Aguiar S, et al. Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype. J Clin Microbiol. 2011;49:1369-1375.
11. Sandgren A, Sjostrom K, Olsson-Liljequist B, et al. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae J Infect Dis. 2004;189:785-796.
12. Gratten M, Morey F, Dixon J, et al. An outbreak of serotype 1 Streptococcus pneumoniae infection in central Australia. Med J Aust. 1993;158:340-342.
13. Dagan R, Gradstein S, Belmaker I, et al. An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel. Clin Infect Dis. 2000;30:319-321.
14. Musher DM. Pneumococcal outbreaks in nursing homes. N Engl J Med. 1998;338:1915-1916.
15. Fraser D, Givon-Lavi N, Bilenko N, et al. A decade (1989-1998) of pediatric invasive pneumococcal disease in 2 populations residing in 1 geographic location: implications for vaccine choice. Clin Infect Dis. 2001;33:421-427.
16. The Israel Bureau of Statistics, 2011. Available at: http://www.cbs.gov. il/shnaton62/st02-10x.pdf. Accessed February 1, 2013.
17. State of Israel. Ministry of Health. Health Status of Bedouin Infants and Children Younger than 6 Years of Age Living in Permanent Dwelling and Unrecognized Villages in the Negev. Israel: Ministry of Health Southern District; 2008.
18. Shouval DS, Greenberg D, Givon-Lavi N, et al. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Pediatr Infect Dis J. 2009;28:277-282.
19. American Academy of Pediatrics. Pneumococcal infections. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:524-535.
20. Ampofo K, Pavia AT, Chris S, et al. The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance. Pediatr Infect Dis J. 2012;31:228-234.
21. Sirotnak A P, Eppes SC, Klein JD. Tuboovarian abscess and peritonitis caused by Streptococcus pneumoniae serotype 1 in young girls. Clin Infect Dis. 1996;22:993-996.
22. Lagos R, Muñoz A, San Martin O, et al. Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994-2007. J Infect Dis. 2008;198:1809-1817.
23. Velez CD, Lewis CJ, Kasper DL, et al. Type I Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II-dependent pathway for antigen presentation. Immunology. 2009;127:73-82.
24. Tzianabos AO, Onderdonk AB, Rosner B, et al. Structural features of polysaccharides that induce intra-abdominal abscesses. Science. 1993;262:416-419.
25. Chung DR, Kasper DL, Panzo RJ, et al. CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol. 2003;170:1958-1963.
26. Picazo J, Ruiz-Contreras J, Casado-Flores J, et al.; Heracles Study Group. Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar. Clin Vaccine Immunol. 2011;18:89-94.
27. DeMaria A Jr, Browne K, Berk SL, et al. An outbreak of type 1 pneumococcal pneumonia in a men's shelter. JAMA. 1980;244:1446-1449.
28. Gessner BD, Mueller JE, Yaro S. African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults. BMC Infect Dis. 2010;10:22.
29. Leimkugel J, Adams Forgor A, Gagneux S, et al. An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis. 2005;192:192-199.
30. Antonio M, Hakeem I, Awine T, et al. Seasonality and outbreak of a predominant Streptococcus pneumoniae serotype 1 clone from The Gambia: expansion of ST217 hypervirulent clonal complex in West Africa. BMC Microbiol. 2008;8:198.
31. Porat N, Benisty R, Trefler R, et al. Clonal distribution of common pneumococcal serotypes not included in the 7-valent conjugate vaccine (PCV7): marked differences between two ethnic populations in southern Israel. J Clin Microbiol. 2012;50:3472-3477.
32. Harvey RM, Stroeher UH, Ogunniyi AD, et al. A variable region within the genome of Streptococcus pneumoniae contributes to strain-strain variation in virulence. PLoS ONE. 2011;6:e19650.
33. Witzenrath M, Pache F, Lorenz D, et al. The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J Immunol. 2011;187:434-440.
34. Harvey RM, Ogunniyi AD, Chen AY, et al. Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood. Infect Immun. 2011;79:4122-4130.
35. Hausdorff W P. The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease. Vaccine. 2007;25:2406-2412.
36. Sjöström K, Spindler C, Ortqvist A, et al. Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis. 2006;42:451-459.
37. Harboe ZB, Thomsen RW, Riis A, et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med. 2009;6:e1000081.
38. Henriques B, Kalin M, Ortqvist A, et al. Molecular epidemiology of Streptococcus pneumoniae causing invasive disease in 5 countries. J Infect Dis. 2000;182:833-839.
39. Weinberger DM, Harboe ZB, Sanders EA, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis. 2010;51:692-699.
40. Fletcher M, Leeming J, Cartwright K, et al.; South West of England Invasive Community Acquired Infection Study Group. Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2006;25:559-560.
41. Eltringham G, Kearns A, Freeman R, et al. Culture-negative childhood empyema is usually due to penicillin-sensitive Streptococcus pneumoniae capsular serotype 1. J Clin Microbiol. 2003;41:521-522.